Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico

Pediatrics

Volumn 129, Issue 1, 2012, Pages

  Whitmore, Suzanne K ^a   Taylor, Allan W ^a   Espinoza, Lorena ^a   Shouse, R Luke ^a   Lampe, Margaret A ^a   Nesheim, Steven ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV; Risk factors; United States; Vertical infectious disease transmission

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CHILD; CORRELATION ANALYSIS; DEMOGRAPHY; DIAGNOSTIC TEST; FEMALE; HEALTH BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOTHER CHILD RELATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PUERTO RICO; SCHOOL CHILD; SUBSTANCE ABUSE; UNITED STATES; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PUERTO RICO; RISK FACTORS; UNITED STATES;

EID: 84855281125     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-3691     Document Type: Article

References (40)

1. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recomm Rep. 1995;44(RR-7):1-15
2. Institute of Medicine. Reducing the odds: preventing perinatal transmission of HIV in the United States. Washington, DC: National Academies Press; 1999
3. Centers for Disease Control and Prevention. Revised recommendations for HIV screening of pregnant women. MMWR Recomm Rep. 2001;50(RR-19):63-85, quiz CE1-19a2-CE6-19a2
4. Branson BM, Handsfield HH, Lampe MA, et al. Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17, quiz CE1-CE4
5. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Recomm Rep. 1994;43(RR-11):1-20
6. Mofenson LM; Centers for Disease Control and Prevention; U.S. Public Health Service Task Force. US Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Recomm Rep. 2002;51(RR-18):1-38, quiz CE1-4
7. Lindegren ML, Byers RH, Jr, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA. 1999;282(6):531-538 (Pubitemid 29380289)
8. McKenna MT, Hu X. Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States. Am J Obstet Gynecol. 2007;197(3 suppl):S10-S16 (Pubitemid 47347968)
9. Taylor AW, Zhang X, Whitmore SK, Rhodes P, Blair J. Estimated number of perinatal HIV infections in the United States, 2005, 2009. National HIV Prevention Conference, Poster ID Number: 109M
10. Centers for Disease Control and Prevention (CDC). Achievements in public health. Reduction in perinatal transmission of HIV infection - United States, 1985-2005. MMWR Morb Mortal Wkly Rep. 2006;55(21):592-597
11. Peters V, Liu KL, Dominguez K, et al. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort. Pediatrics. 2003;111(5 pt 2):1186-1191 (Pubitemid 36539227)
12. Institute of Medicine and the National Research Council. Reducing the odds: preventing perinatal transmission of HIV in the United States. Stoto MA, Almario DA, McCormick MC, eds. Washington, DC: National Academy Press; 1999. Available at: www.nap.edu/catalog.php?record-id=6307#toc. Accessed December 2010
13. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med. 1999;341(6):385-393 (Pubitemid 29362511)
14. Rich KC, Fowler MG, Mofenson LM, et al. Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group Pediatrics. 2000;105(1). Available at: www.pediatrics.org/cgi/content/full/105/1/e8
15. Simonds RJ, Steketee R, Nesheim S, et al. Perinatal AIDS Collaborative Transmission Studies. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. AIDS. 1998;12(3):301-308 (Pubitemid 28045459)
16. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. N Engl J Med. 1999;340(13):977-987
17. Birkhead GS, Pulver WP, Warren BL, Hackel S, Rodríguez D, Smith L. Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 2002-2006. Obstet Gynecol. 2010;115(6):1247-1255
18. Garcia-Tejedor A, Maiques V, Perales A, Lopez-Aldeguer J. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission. Acta Obstet Gynecol Scand. 2009;88(8):882-887
19. Orloff SL, Bulterys M, Vink P, et al. Perinatal AIDS Collaborative Transmission Study. Maternal characteristics associated with antenatal, intrapartum, and neonatal zidovudine use in four US cities, 1994-1998. J Acquir Immune Defic Syndr. 2001;28(1):65-72 (Pubitemid 33104529)
20. Mofenson LM. Advances in the prevention of vertical transmission of human immunodeficiency virus. Semin Pediatr Infect Dis. 2003;14(4):295-308 (Pubitemid 38139834)
21. Mayaux MJ, Teglas JP, Blanche S; French Pediatric HIV Infection Study Group. Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French Perinatal Cohort. J Acquir Immune Defic Syndr. 2003;34(3):338-343 (Pubitemid 37377370)
22. Caesarean section and risk of vertical transmission of HIV-1 infection. European Collaborative Study. Lancet. 1994;343(8911):1464-1467
23. Jamieson DJ, Read JS, Kourtis AP, Durant TM, Lampe MA, Dominguez KL. Cesarean delivery for HIV-infected women: recommendations and controversies. Am J Obstet Gynecol. 2007;197(3 suppl):S96-S100 (Pubitemid 47354182)
24. Harris NS, Fowler MG, Sansom SL, Ruffo N, Lampe MA. Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001. Am J Obstet Gynecol. 2007;197(3 suppl):S33-S41 (Pubitemid 47354190)
25. Centers for Disease Control and Prevention. Enhanced perinatal surveillance - 15 areas, 2005-2008. HIV Surveillance Supplemental Report 2011;16(2). Available at: www.cdc.gov/hiv/topics/surveillance/resources/reports/ . Accessed April 2011.
26. Whitmore SK, Patel-Larson A, Espinoza L, Ruffo NM, Rao S. Missed opportunities to prevent perinatal human immunodeficiency virus transmission in 15 jurisdictions in the United States during 2005-2008. Women Health. 2010;50(5):414-425
27. Centers for Disease Control and Prevention. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years - United States, 2008. MMWR Recomm Rep. 2008;57(RR-10):1-12. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/rr5710a1.htm?s-cid=rr5710a1-e . Accessed November 2009
28. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29(5):484-494 (Pubitemid 34456340)
29. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354(9181):795-802 (Pubitemid 29415583)
30. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331(18):1173-1180 (Pubitemid 24331334)
31. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Recomm Rep. 1994;43(RR-11):1-20
32. Magder LS, Mofenson L, Paul ME, et al. Risk factors for in utero and intrapartum transmission of HIV. J Acquir Immune Defic Syndr. 2005;38(1):87-95 (Pubitemid 40094125)
33. Centers for Disease Control (CDC). Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1985;34(48):721-726, 731-732
34. D'Ippolito M, Read JS, Korelitz J, João EC, Mussi-Pinhata M, Rocha N; NISDI Perinatal Study Group. Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Latin America and the Caribbean: the NISDI perinatal study. Pediatr Infect Dis J. 2007;26(7):649-653 (Pubitemid 47014172)
35. Datta P, Embree JE, Kreiss JK, et al. Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study. J Infect Dis. 1994;170(5):1134-1140 (Pubitemid 24328615)
36. Thea DM, Steketee RW, Pliner V, et al. New York City Perinatal HIV Transmission Collaborative Study Group. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. AIDS. 1997;11(4):437-444 (Pubitemid 27113004)
37. Arvold ND, Ngo-Giang-Huong N, McIntosh K, et al. Perinatal HIV Prevention Trial (PHPT-1), Thailand. Maternal HIV-1 DNA load and mother-to-child transmission. AIDS Patient Care STDS. 2007;21(9):638-643 (Pubitemid 47525386)
38. Montano M, Russell M, Gilbert P, et al. Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers. J Infect Dis. 2003;188(3):406-413 (Pubitemid 36960651)
39. Garcia PM, Kalish LA, Pitt J, et al. Women and Infants Transmission Study Group. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med. 1999;341(6):394-402 (Pubitemid 29362512)
40. Whitmore SK, Zhang X, Taylor AW, Blair JM. Estimated number of infants born to HIV-infected women in the United States and Five Dependent Areas, 2006. J Acquir Immune Defic Syndr. 2011;57(3):218-222